Malaria Control : Improving Access to Prevention, Diagnostic and Care for Vulnerable Rural Communities

Not Applicable

Recruiting

• Conditions: Malaria
• Interventions: Other: Public health intervention

• Registration Number: NCT05535465
• Lead Sponsor: Institut de Recherche pour le Developpement

Brief Summary

In the REACT 2 project, a consortium proposes to study in Burkina Faso and Côte d'Ivoire, the impact of a public health intervention in rural communities in order to improve access to malaria therapeutic and preventive arsenal for vulnerable populations (i.e. children, adolescents and pregnant women). The intervention relies on the implementation of mobile health workers to support community health workers.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-12-01
• Study First Submitted: 2022-08-24
• Status Verified: 2022-09
• Study First Submitted QC: 2022-09-06
• Last Update Submitted: 2022-09-06
• Study First Posted: 2022-09-10
• Last Update Posted: 2022-09-10
• Primary Completion: 2024-02-01
• Study Completion: 2024-09-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 7500

Inclusion Criteria

• global population

Exclusion Criteria

• absence of informed consent

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Intervention arm	Public health intervention	Heath system strengthening with additional trained mobile health care worker to help community health workers

Primary Outcome Measures

Name	Time	Method
Difference of malaria incidence between control and intervention arms	Day 0 (cross-sectional survey)	Incidence will be calculated as the number of malaria cases detected during the cross-sectionnal surveys relative to the population size

Secondary Outcome Measures

Name	Time	Method
Difference of malaria prevalence between control and intervention arms	Day 0 (cross-sectional survey)	Prevalence will be calculated as the proportion of participants with malaria infection (i.e. positive blood smears) detected during the cross-sectionnal surveys

Trial Locations

Locations (2)

IPR; 🇨🇮 Bouaké, Côte D'Ivoire

IRSS; 🇧🇫 Bobo-Dioulasso, Houet, Burkina Faso